‘Champix,’ beneficiary of the governmental antismoking support business, increases quadruple in prescriptions

Since the government’s antismoking support business was invigorated this year, the market of antismoking treatments has grown significantly.

The product which led the growth was ‘Champix(varenicline),’ a Pfizer’s antismoking treatment, known to receive the most benefits due the support business of the government.

According to the IMS data until the 3^rd quarter of this year, Champix recorded t...